Stay updated with breaking news from Development Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck a leading science and technology company today announced a licensing agreement with Inspirna Inc. New York NY for ompenaclid RGX202 a firstinclass oral inhibitor of the creatine transport channel SLC6A8 and SLC6A8targeting followon compounds.
Discover 2023's Akamai Technologies statistics, highlighting their remarkable influence in content delivery and cybersecurity.
‘Vaccelerate’ programme is already on the look-out for the next 'pathogen with pandemic potential.'
Ten University of Cape Town (UCT) researchers have been inducted as members of the Academy of Science of South Africa (ASSAf). Concurrently, the South African Young Academy of Science (SAYAS) admitted one researcher from UCT.Induction to ASSAf is a t
Parliament on Thursday approved GH¢2,074,827,164 budgetary estimates for the office of government machinery for the year ending December...